PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study to Learn More About the Menopausal Hormone Therapies in Korea
- Conditions
- Bone DemineralizationMenopause
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1036294
- Registration Number
- NCT06033521
- Locations
- 🇰🇷
Pfizer South Korea, Seoul, Korea, Republic of
A Retrospective Validation Study To Identify Chart-Based Clinical Diagnosis Of Wild-Type Transthyretin Amyloid Cardiomyopathy (Attrwt-CM) And Non-Amyloid Heart Failure Among Patients With Heart Failure (HF).
- Conditions
- ATTR-CM
- Interventions
- Other: Machine learning algorithm
- First Posted Date
- 2023-09-08
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 558
- Registration Number
- NCT06029452
- Locations
- 🇺🇸
Pfizer, New York, New York, United States
Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients.
- Conditions
- Colitis, Ulcerative
- First Posted Date
- 2023-09-06
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Pfizer
- Registration Number
- NCT06025227
A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia
- First Posted Date
- 2023-08-29
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 248
- Registration Number
- NCT06016556
- Locations
- 🇸🇦
Saudi Arabia, Riyadh, Saudi Arabia
🇸🇦King Faisal Specialist Hospital & research center - Jeddah, Jeddah, Saudi Arabia
🇸🇦King Abdulaziz Medical City, Riyadh, Saudi Arabia
A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy Participants
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2024-01-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT06005688
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
A Study to Learn How Different Amounts of the Study Medicine Called PF-06954522 Are Tolerated and Act in the Body in Healthy Adults
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 26
- Registration Number
- NCT06003777
- Locations
- 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States
A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants.
- Conditions
- Healthy
- Interventions
- Drug: SinsunatovirOther: Bitrex
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT06003829
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 472
- Registration Number
- NCT06003114
- Locations
- 🇨🇦
Alberta Health Services, Edmonton, Alberta, Canada
A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco
- First Posted Date
- 2023-08-18
- Last Posted Date
- 2024-03-28
- Lead Sponsor
- Pfizer
- Registration Number
- NCT05997485
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 340
- Registration Number
- NCT05995964
- Locations
- 🇺🇸
Allervie Clinical Research, Birmingham, Alabama, United States
🇺🇸Medical Dermatology Specialists, Phoenix, Arizona, United States
🇺🇸Banner - University Medicine Dermatology Clinic, Tucson, Arizona, United States